| Zaman, K |
NCT05677256: A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 |
|
|
| Active, not recruiting | 4 | 500 | RoW | nOPV2 | Fidec Corporation, Bill and Melinda Gates Foundation | Poliomyelitis | 02/24 | 07/24 | | |
NCT06114810: Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV |
|
|
| Not yet recruiting | 4 | 880 | NA | polio vaccines: nOPV2, bOPV, IPV | International Centre for Diarrhoeal Disease Research, Bangladesh, Centers for Disease Control and Prevention, Government of Bangladesh | Polio | 06/24 | 09/24 | | |
NCT05163561: Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine |
|
|
| Completed | 3 | 1072 | RoW | SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot B, SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot C, Sii Licensed IPV | Serum Institute of India Pvt. Ltd. | Poliomyelitis | 04/23 | 04/23 | | |
NCT06413121: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV |
|
|
| Recruiting | 3 | 1557 | RoW | Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Reduced Dose IPV, Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV | Serum Institute of India Pvt. Ltd. | Diptheria Immunization, Tetanus Immunization, Pertussis Immunization, Hepatitis B Immunization, Haemophilus Influenzae Type B Immunization, Polio Immunization | 08/25 | 05/26 | | |
NCT05644184: Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh |
|
|
| Recruiting | 2 | 1683 | RoW | Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1) | PATH, Bill and Melinda Gates Foundation, PT Bio Farma, Centers for Disease Control and Prevention, DiagnoSearch Life Sciences Pvt. Ltd. | Poliomyelitis | 02/25 | 02/25 | | |
NCT06137664: Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines |
|
|
| Not yet recruiting | 1/2 | 2400 | RoW | Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2), Novel oral poliomyelitis vaccine type 3 (nOPV3), Bivalent Oral Poliomyelitis Vaccine (bOPV) | PATH, Bio Farma, Indonesia | Poliomyelitis | 12/27 | 12/27 | | |
